Pharmacy

As Medicare’s GLP-1 Bridge Program Launches, ISMP Offers Guidance for Pharmacists

Omadacycline Trial Offers a Rare Win for NTM, While Shorter TB Treatment Regimens Are Limited by Toxicities

Rethinking Inpatient IV Default for PWID With Serious Injection-Related Infections

ASHP Futures 2026: Tips for Hazardous Drug Wipe Sampling

Pediatric Iron Deficiency: New Ferritin Thresholds, and a Wider Role for Pharmacy

IV Iron During Acute Infection Linked to Lower Mortality, Real-World Analysis Finds

Action Steps for Reimbursement Readiness

Emerging Therapies For Blood Cancers

ASHP Futures 2025: Medication Safety in the AI Era

A Plague on Patient Assistance

Decnupaz Approved for Blastic Plasmacytoid Dendritic Cell Neoplasms

ASHP Futures 2026: Proactive Tools to Modernize Medication Safety

As Manufacturers Catch On to Alternative Funding Programs, More Specialty Patients Routed to Overseas Pharmacies

Ambulatory Care Pharmacists Drive Higher Specialty Prescription Capture

ASHP Calls on HHS to Halt Lilly’s 340B Data Cutoff